159 related articles for article (PubMed ID: 15947554)
1. Bilirubin response to corticosteroids in severe alcoholic hepatitis.
Morris JM; Forrest EH
Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):759-62. PubMed ID: 15947554
[TBL] [Abstract][Full Text] [Related]
2. A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.
Garcia-Saenz-de-Sicilia M; Duvoor C; Altamirano J; Chavez-Araujo R; Prado V; de Lourdes Candolo-Martinelli A; Holanda-Almeida P; Becerra-Martins-de-Oliveira B; Fernandez-de-Almeida S; Bataller R; Caballeria J; Duarte-Rojo A
Am J Gastroenterol; 2017 Feb; 112(2):306-315. PubMed ID: 27922027
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
[TBL] [Abstract][Full Text] [Related]
4. The management of alcoholic hepatitis: a prospective comparison of scoring systems.
Lafferty H; Stanley AJ; Forrest EH
Aliment Pharmacol Ther; 2013 Sep; 38(6):603-10. PubMed ID: 23879668
[TBL] [Abstract][Full Text] [Related]
5. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone.
Mathurin P; Abdelnour M; Ramond MJ; Carbonell N; Fartoux L; Serfaty L; Valla D; Poupon R; Chaput JC; Naveau S
Hepatology; 2003 Dec; 38(6):1363-9. PubMed ID: 14647046
[TBL] [Abstract][Full Text] [Related]
6. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids.
Louvet A; Diaz E; Dharancy S; Coevoet H; Texier F; Thévenot T; Deltenre P; Canva V; Plane C; Mathurin P
J Hepatol; 2008 Mar; 48(3):465-70. PubMed ID: 18164508
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial.
Park SH; Kim DJ; Kim YS; Yim HJ; Tak WY; Lee HJ; Sohn JH; Yoon KT; Kim IH; Kim HS; Um SH; Baik SK; Lee JS; Suk KT; Kim SG; Suh SJ; Park SY; Kim TY; Jang JY;
J Hepatol; 2014 Oct; 61(4):792-8. PubMed ID: 24845609
[TBL] [Abstract][Full Text] [Related]
8. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
Sharma P; Kumar A; Sharma BC; Sarin SK
J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
[TBL] [Abstract][Full Text] [Related]
9. Prednisolone plus S-adenosil-L-methionine in severe alcoholic hepatitis.
Tkachenko P; Maevskaya M; Pavlov A; Komkova I; Pavlov C; Ivashkin V
Hepatol Int; 2016 Nov; 10(6):983-987. PubMed ID: 27337960
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
Nguyen-Khac E; Thevenot T; Piquet MA; Benferhat S; Goria O; Chatelain D; Tramier B; Dewaele F; Ghrib S; Rudler M; Carbonell N; Tossou H; Bental A; Bernard-Chabert B; Dupas JL;
N Engl J Med; 2011 Nov; 365(19):1781-9. PubMed ID: 22070475
[TBL] [Abstract][Full Text] [Related]
11. In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis.
di Mambro AJ; Parker R; McCune A; Gordon F; Dayan CM; Collins P
Hepatology; 2011 Apr; 53(4):1316-22. PubMed ID: 21400552
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Granulocyte Colony-stimulating Factor in the Management of Steroid-Nonresponsive Severe Alcoholic Hepatitis: A Double-Blind Randomized Controlled Trial.
Shasthry SM; Sharma MK; Shasthry V; Pande A; Sarin SK
Hepatology; 2019 Sep; 70(3):802-811. PubMed ID: 30664267
[TBL] [Abstract][Full Text] [Related]
13. A prognostic evaluation and management of alcoholic hepatitis.
Rana R; Wang SL; Li J; Xia L; Song MY; Yang CQ
Minerva Med; 2017 Dec; 108(6):554-567. PubMed ID: 28602070
[TBL] [Abstract][Full Text] [Related]
14. The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids.
Forrest EH; Morris AJ; Stewart S; Phillips M; Oo YH; Fisher NC; Haydon G; O'Grady J; Day CP
Gut; 2007 Dec; 56(12):1743-6. PubMed ID: 17627961
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.
Singh V; Sharma AK; Narasimhan RL; Bhalla A; Sharma N; Sharma R
Am J Gastroenterol; 2014 Sep; 109(9):1417-23. PubMed ID: 24935272
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.
Louvet A; Thursz MR; Kim DJ; Labreuche J; Atkinson SR; Sidhu SS; O'Grady JG; Akriviadis E; Sinakos E; Carithers RL; Ramond MJ; Maddrey WC; Morgan TR; Duhamel A; Mathurin P
Gastroenterology; 2018 Aug; 155(2):458-468.e8. PubMed ID: 29738698
[TBL] [Abstract][Full Text] [Related]
17. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial.
Carithers RL; Herlong HF; Diehl AM; Shaw EW; Combes B; Fallon HJ; Maddrey WC
Ann Intern Med; 1989 May; 110(9):685-90. PubMed ID: 2648927
[TBL] [Abstract][Full Text] [Related]
18. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score.
Forrest EH; Evans CD; Stewart S; Phillips M; Oo YH; McAvoy NC; Fisher NC; Singhal S; Brind A; Haydon G; O'Grady J; Day CP; Hayes PC; Murray LS; Morris AJ
Gut; 2005 Aug; 54(8):1174-9. PubMed ID: 16009691
[TBL] [Abstract][Full Text] [Related]
19. Alcoholic hepatitis: Towards an era of personalised management.
Degré D; Wandji LCN; Moreno C; Louvet A
United European Gastroenterol J; 2020 Nov; 8(9):995-1002. PubMed ID: 32718222
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
Mathurin P; Mendenhall CL; Carithers RL; Ramond MJ; Maddrey WC; Garstide P; Rueff B; Naveau S; Chaput JC; Poynard T
J Hepatol; 2002 Apr; 36(4):480-7. PubMed ID: 11943418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
